Last reviewed · How we verify
NCT03455868: BODI
Bone Health After Bariatric Surgery in Patients With Type 2 Diabetes
trial testing Bariatric surgery in Bariatric Surgery in 100 participants. Currently enrolling.
1 December 2025
Quick facts
| Lead sponsor | CHU de Quebec-Universite Laval |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 15 March 2018 |
| Primary completion | 1 December 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 3 locations across Canada |
Drugs / interventions tested
- Bariatric surgery
Conditions studied
- Bariatric Surgery — all drugs for Bariatric Surgery →
- Bone Health — all drugs for Bone Health →
- Obesity, Morbid — all drugs for Obesity, Morbid →
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Sponsor
CHU de Quebec-Universite Laval — full company profile →
Who can join
Adults 18 to 60, any sex, with Bariatric Surgery or Bone Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Bone fragility is a complication of type 2 diabetes. Diabetes treatments may ameliorate or deteriorate bone fragility in this population. Bariatric surgery is gaining in popularity in people with type 2 diabetes and may impact bone health. Objectives: To evaluate the impact of the most popular bariatric procedure worldwide (sleeve gastrectomy (SG)) on vBMD by QCT in patients with type 2 diabetes; Secondary aims: (1) to identify the determinants of vBMD after bariatric surgery in patients with type 2 diabetes; (2) to compare vBMD and its potential determinants after bariatric surgery with obese controls without diabetes as well as with controls without obesity and normoglycemia.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Link Between the Gut Microbiome and Bone Metastasis.
Sevcikova A, Martiniakova M, Omelka R, Stevurkova V, et al · · 2024 · cited 5× · PMID 39596154 · DOI 10.3390/ijms252212086 -
Oral vitamin D supplementation for adults with obesity undergoing bariatric surgery.
Chakhtoura MT, Nakhoul NF, Akl EA, Safadi BY, et al · · 2024 · cited 4× · PMID 39351881 · DOI 10.1002/14651858.cd011800.pub2
Verify or expand the search:
- PubMed search for NCT03455868
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Bariatric surgery
Trials testing the same drug.
- NCT06564610 — Laparoscopic Transversus Abdominis Plane Block Versus Erector Spinae Plane Block in Bariatric Surgery · NA · completed
- NCT07289555 — Tailored Stapled SADI-S: Initial Report and Preliminary Results · NA · recruiting
- NCT06346145 — Impact of Bariatric Surgery on Heart Disease Compared to Standard Care · NA · not yet recruiting
- NCT06874309 — Non-invasive Brain Stimulation to Prepare the Patient for Bariatric Surgery (REBAS) · NA · recruiting
- NCT06420479 — The Causal Effect of Bariatric Surgery on Cardiovascular Disease and Mortality · recruiting
Other recruiting trials for Bariatric Surgery
Currently open trials in the same condition.
- NCT07430111 — Flow-Controlled Versus Volume-Controlled Ventilation in Bariatric Surgery · NA · recruiting
- NCT07324447 — EFFECTS OF SUPERVISED PHYSICAL EXERCISE AFTER BARIATRIC SURGERY ON MUSCLE MASS AND BONE DENSITY (OBEFIT STUDY) · NA · recruiting
- NCT07286968 — Gastro-Intestinal Digestion and Physiology After Bariatric Surgery · recruiting
- NCT07289958 — Effects of Respiratory Muscle Training in Post-bariatric Surgery Patients · NA · recruiting
- NCT07327905 — Intravenous Lidocaine Infusion Versus Intravenous Dexmedetomidine Infusion During Sleeve Gastrectomy · NA · recruiting
Other CHU de Quebec-Universite Laval trials
Trials by the same sponsor.
- NCT07067827 — Self-questionnaire in Osteoporosis · recruiting
- NCT06018116 — A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer. · Phase 2 · withdrawn
- NCT05941806 — Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum Resection · Phase 3 · unknown
- NCT06351176 — Impact of Glycemic Control on Skeletal Outcomes in Adults With Type 1 Diabetes · enrolling by invitation
- NCT05859139 — Scaling a Decision Aid on Prenatal Screening for Trisomy 21, 18 and 13 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03455868 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CHU de Quebec-Universite Laval
- Last refreshed: 10 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03455868.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing